| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| UNITED STATES | Region | 2025 | USD | 53,752.0 | 57.1% |
| Europe | Region | 2025 | USD | 21,535.0 | 22.9% |
| Asia-Pacific, Africa | Region | 2025 | USD | 14,031.0 | 14.9% |
| Western Hemisphere, excluding U.S. | Region | 2025 | USD | 4,875.0 | 5.2% |
| UNITED STATES | Region | 2024 | USD | 50,302.0 | 56.6% |
| Europe | Region | 2024 | USD | 20,212.0 | 22.8% |
| Asia-Pacific, Africa | Region | 2024 | USD | 13,593.0 | 15.3% |
| Western Hemisphere, excluding U.S. | Region | 2024 | USD | 4,714.0 | 5.3% |
| UNITED STATES | Region | 2023 | USD | 46,444.0 | 54.5% |
| Europe | Region | 2023 | USD | 20,410.0 | 24.0% |
| Asia-Pacific, Africa | Region | 2023 | USD | 13,756.0 | 16.2% |
| Western Hemisphere, excluding U.S. | Region | 2023 | USD | 4,549.0 | 5.3% |
| UNITED STATES | Region | 2022 | USD | 48,580.0 | 51.2% |
| Europe | Region | 2022 | USD | 23,449.0 | 24.7% |
| Asia-Pacific, Africa | Region | 2022 | USD | 16,789.0 | 17.7% |
| Western Hemisphere, excluding U.S. | Region | 2022 | USD | 6,125.0 | 6.5% |
| UNITED STATES | Region | 2021 | USD | 47,156.0 | 50.3% |
| Europe | Region | 2021 | USD | 23,594.0 | 25.2% |
| Asia-Pacific, Africa | Region | 2021 | USD | 17,275.0 | 18.4% |
| Western Hemisphere, excluding U.S. | Region | 2021 | USD | 5,750.0 | 6.1% |
| UNITED STATES | Region | 2020 | USD | 43,133.0 | 52.2% |
| Europe | Region | 2020 | USD | 18,980.0 | 23.0% |
| Asia-Pacific, Africa | Region | 2020 | USD | 15,136.0 | 18.3% |
| Western Hemisphere, excluding U.S. | Region | 2020 | USD | 5,335.0 | 6.5% |
| Innovative Medicine | Product | 2025 | USD | 60,401.0 | 64.1% |
| MedTech | Product | 2025 | USD | 33,792.0 | 35.9% |
| Innovative Medicine | Product | 2024 | USD | 56,964.0 | 64.1% |
| MedTech | Product | 2024 | USD | 31,857.0 | 35.9% |
| Innovative Medicine | Product | 2023 | USD | 54,759.0 | 64.3% |
| MedTech | Product | 2023 | USD | 30,400.0 | 35.7% |
| Innovative Medicine | Product | 2022 | USD | 52,563.0 | 55.4% |
| MedTech | Product | 2022 | USD | 27,427.0 | 28.9% |
| Consumer | Product | 2022 | USD | 14,953.0 | 15.8% |
| Pharmaceutical | Product | 2021 | USD | 52,080.0 | 55.5% |
| Medical Devices | Product | 2021 | USD | 27,060.0 | 28.9% |
| Consumer | Product | 2021 | USD | 14,635.0 | 15.6% |
| Pharmaceutical | Product | 2020 | USD | 45,175.0 | 54.7% |
| Medical Devices | Product | 2020 | USD | 22,959.0 | 27.8% |
| Consumer | Product | 2020 | USD | 14,450.0 | 17.5% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
